Fig. 5From: Cancer nanotechnology: current status and perspectivesMultiple types of heterogeneity require consideration when treating cancer patients including patient tumors, multi-focal disease, intra-tumor cellular heterogeneity, genomic heterogeneity, and epigenetic heterogeneity. Reprinted with permission, [119]Â https://doi.org/10.20517/2394-4722.2017.34Back to article page